Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
API Stability Enhancers
Topical
Thickeners and Stabilizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
93
PharmaCompass offers a list of Meglumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Meglumine manufacturer or Meglumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Meglumine manufacturer or Meglumine supplier.
A N-Methyl-D-Glucamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Methyl-D-Glucamine, including repackagers and relabelers. The FDA regulates N-Methyl-D-Glucamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Methyl-D-Glucamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N-Methyl-D-Glucamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A N-Methyl-D-Glucamine supplier is an individual or a company that provides N-Methyl-D-Glucamine active pharmaceutical ingredient (API) or N-Methyl-D-Glucamine finished formulations upon request. The N-Methyl-D-Glucamine suppliers may include N-Methyl-D-Glucamine API manufacturers, exporters, distributors and traders.
click here to find a list of N-Methyl-D-Glucamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A N-Methyl-D-Glucamine DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Methyl-D-Glucamine active pharmaceutical ingredient (API) in detail. Different forms of N-Methyl-D-Glucamine DMFs exist exist since differing nations have different regulations, such as N-Methyl-D-Glucamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Methyl-D-Glucamine DMF submitted to regulatory agencies in the US is known as a USDMF. N-Methyl-D-Glucamine USDMF includes data on N-Methyl-D-Glucamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Methyl-D-Glucamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Methyl-D-Glucamine suppliers with USDMF on PharmaCompass.
A N-Methyl-D-Glucamine CEP of the European Pharmacopoeia monograph is often referred to as a N-Methyl-D-Glucamine Certificate of Suitability (COS). The purpose of a N-Methyl-D-Glucamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N-Methyl-D-Glucamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N-Methyl-D-Glucamine to their clients by showing that a N-Methyl-D-Glucamine CEP has been issued for it. The manufacturer submits a N-Methyl-D-Glucamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a N-Methyl-D-Glucamine CEP holder for the record. Additionally, the data presented in the N-Methyl-D-Glucamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N-Methyl-D-Glucamine DMF.
A N-Methyl-D-Glucamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N-Methyl-D-Glucamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N-Methyl-D-Glucamine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-Methyl-D-Glucamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-Methyl-D-Glucamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-Methyl-D-Glucamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-Methyl-D-Glucamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-Methyl-D-Glucamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-Methyl-D-Glucamine suppliers with NDC on PharmaCompass.
N-Methyl-D-Glucamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Methyl-D-Glucamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right N-Methyl-D-Glucamine GMP manufacturer or N-Methyl-D-Glucamine GMP API supplier for your needs.
A N-Methyl-D-Glucamine CoA (Certificate of Analysis) is a formal document that attests to N-Methyl-D-Glucamine's compliance with N-Methyl-D-Glucamine specifications and serves as a tool for batch-level quality control.
N-Methyl-D-Glucamine CoA mostly includes findings from lab analyses of a specific batch. For each N-Methyl-D-Glucamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Methyl-D-Glucamine may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Methyl-D-Glucamine EP), N-Methyl-D-Glucamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Methyl-D-Glucamine USP).
